Showing results (361-370 of 636) with videos related to
Sort By:
Pageof 64
Journal of Palliative Medicine|July 17, 2020
Patterns of Opioid Prescribing among Medicare Advantage Beneficiaries with Pain and Cardiopulmonary ConditionsShelli L Feder, Maureen E Canavan, Shiyi Wang, et al.Medical Care|February 14, 2018
Changes in Health Insurance Coverage Associated With the Affordable Care Act Among Adults With and Without a Cancer History: Population-based National EstimatesAmy J Davidoff, Gery P Guy, Xin Hu, et al.Journal of Oncology Practice|January 8, 2015
Patient cost sharing and receipt of erythropoiesis-stimulating agents through medicare part DAmy J Davidoff, Franklin B Hendrick, Amer M Zeidan, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 17, 2015
Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer's diseaseAlicia M Hall, Benjamin T Throesch, Susan C Buckingham, et al.Journal of Translational Medicine|June 15, 2023
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementiaMichael Kurnellas, Ananya Mitra, Tina Schwabe, et al.Journal of Geriatric Oncology|June 26, 2018
Functional trajectories before and after a new cancer diagnosis among community-dwelling older adultsC J Presley, Ling Han, Linda Leo-Summers, et al.Haematologica|January 3, 2012
Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromesAmy J Davidoff, Sheila Weiss Smith, Maria R Baer, et al.The American Journal of Managed Care|July 27, 2021
ACA Medicaid expansion association with racial disparity reductions in timely cancer treatmentBlythe J S Adamson, Aaron B Cohen, Cary P Gross, et al.Therapeutic Advances in Hematology|February 14, 2022
Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United StatesRory M Shallis, Rong Wang, Jan P Bewersdorf, et al.Journal of Comparative Effectiveness Research|March 14, 2018
Development and validation of a claims-based approach to proxy ECOG performance status across ten tumor groupsKristin M Sheffield, Lee Bowman, David M Smith, et al.Pageof 64